BREAST CANCER BASE

The 17th session of Miami, will provide breast cancer, according to a report known as an MRI imaging technology as monitoring the success rate of breast cancer treatment an effective tool. University of California, Dr. Laura J. Esserman noted that MRI enables doctors an opportunity to look at mass, and the therapeutic effects were observed. MRI imaging technology, can acquire large mass the size, type and consistency, as well as the size of tumors and vascular system to be evaluated. Researchers studied 33 two or three cases of breast cancer patients. The four treatment (chemotherapy and MRI imaging scan) treatment, the researchers found that MRI can accurately show the tumor after chemotherapy in size, mass and determine location accuracy than using only physical diagnosis to be much higher.

Breast cancer tumor size is not the standard to judge <BR> Canada McGuire (McGill), the University Health Center scientists found that breast cancer patients, clinicians have detected in breast tumor size, and with sufficient accuracy to the diagnosis of cancer course, but also not the assertions whether the cancer has been expanded, thus violating lymphoid organs.
The University of genes Jurists Dr. William Foulkes and its research, analysis tracking more than 1,500 breast cancer patients, confirmed indeed there is a category of patients suffering from breast cancer tumor size and duration, in violation of long-standing clinical judgment of physicians, researchers tracking further revealed that the group with the BRCA1 gene mutation have the phenomenon, with clinicians past standards, but the problem is the BRCA2 gene.
The results allow clinicians very surprised because in the past the evidence of BRCA-1 problem, the patient is mostly uncontrolled malignancies, and the results showed that even a very small tumor, diagnosed as early BRCA-2 gene mutation, it is very likely the lymphatic system The cancer has been attacked.

Women in the age of 50 to enter menopause, postmenopausal breast lack of estrogen to stimulate the shrinking gradually, gradually degraded glands. Menopause ovarian function is a manifestation of the recession, small breast size changes, relaxation and drooping skin fold increase.

Because of these series of changes, postmenopausal women to reduce breast size. But there are also some obese women, but breast volume increase, which is due to the excessive gland was replaced by fatty tissue. Still, not breast development, as some women catheter expand cyst formation, and the residual breast and fibrous tissue proliferation of mixed together, so there irregular breast nodules.